Abbott clinical biochemical glucose test panel
Taiwan·Risk Class 2·ABBOTT LABORATORIES·Registered Jun 22, 2007 – Jun 22, 2012Cancelled- Analysis ID
- b63996e88767e4505bed5b218fd98875
- Customs Code
- DHA00601828700
- Manufacturer
- ABBOTT LABORATORIES
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- For the quantitative analysis of glucose in human serum, plasma, urine, or spinal fluid.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- import
- Registration Date
- Jun 22, 2007
- Expiry Date
- Jun 22, 2012
- Cancellation Date
- Apr 16, 2014
- Status
- Logged out
- Reason
- 許可證已逾有效期
Top companies providing products similar to "Abbott clinical biochemical glucose test panel"
Recently registered similar products
Access comprehensive regulatory information for Abbott clinical biochemical glucose test panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b63996e88767e4505bed5b218fd98875 and manufactured by ABBOTT LABORATORIES. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.